Drug manufacturer vendor Kalderos says it expects several companies to begin using its 340B Pay platform during the next three months.
Kalderos Expects its 340B Rebate Model Will Finally Lift Off During Q1 2021
Drug manufacturer reimbursement vendor Kalderos expects “a number of manufacturers” will begin using its 340B Pay software platform during the first quarter of 2021, the company told 340B Report last night. “We are fielding a high level of interest from drug manufacturers of all sizes,” the company said.